Clinical trial
An Italian Database-based Randomized Controlled Trial With Rituximab in Patients With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
NCT06325943 is registered in ClinicalTrials.gov with Istituto Clinico Humanitas as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Italian Database-based Randomized Controlled Trial With Rituximab in Patients With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
- Lead sponsor
- Istituto Clinico Humanitas
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- April 1, 2019
- Completion date
- November 30, 2023
- Enrollment
- 37 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.